Free CME from PeerView


Dermatology CME

Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing the Burden of Prurigo Nodularis: Expert Insight on Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
April 28, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Linking Immunotherapy to Better Outcomes in Resectable Melanoma: Guidance on Integrating Immune-Based Adjuvant and Neoadjuvant Options
March 10, 2022
Credits: 1 CME
PVI, PeerView Institute for Medical Education
Expert Insights From Around the Globe on Tailoring Treatment for Patients With Atopic Dermatitis
November 03, 2021
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Changing the Game for Patients With Prurigo Nodularis: Best Practices to Achieve Treatment Goals and Improve Quality of Life
October 29, 2021
Credits: 0.50 CME / NCPD
Medical Learning Institute, Inc.
Test Your Knowledge of New and Emerging Therapies for Moderate to Severe Atopic Dermatitis: Latest Evidence and Clinical Potential
September 17, 2021
April W. Armstrong, MD, MPH
Credits: 1.0 CME
Medical Learning Institute, Inc.
Taking Aim at the TYK2 Pathway in Psoriasis: Addressing Unmet Treatment and Patient Needs With an Innovative Therapeutic Approach
September 17, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
July 15, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
July 07, 2021
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Innovative Immunotherapy in Advanced Basal Cell Carcinoma: Evolving Science, Key Clinical Evidence, and Implications for Multidisciplinary Management
June 25, 2021
Credits: 0.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Beyond TNF Inhibitors: Latest and Emerging Evidence on Novel Cytokine-Modulating Strategies in the Treatment of Moderate to Severe Psoriasis
June 17, 2021
Jonathan I. Silverberg, MD, PhD, MPH / Eric Simpson, MD, MCR
Credits: 1.00 CME / MOC / NCPD
Medical Learning Institute, Inc.
Advancing Care for People Living With Moderate to Severe Atopic Dermatitis: The Future Looks Clear
May 26, 2021